National Institutes of Health and National Institute of Allergy and Infectious Diseases

Selected news for the healthcare topic - National Institutes of Health, and the healthcare topic - National Institute of Allergy and Infectious Diseases We have 1,364 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/5/2021 US Grant To Wuhan Lab To Enhance Bat-Based Coronaviruses Was Never Scrutinized By HHS Review Board, NIH Says The National Institutes of Health has ‚Ausystematically thwarted‚Au government oversight of dangerous pathogen research, Rutgers University professor of chemical biology Richard H. Ebright told the Daily Caller News Foundation. - The P3CO Review Framework was ... Virology prior to the pandemic bypassed P3CO review because the National Institute of Allergy and Infectious Diseases, led by Anthony Fauci, didn‚Aot flag the project for review. An oversight board created to scrutinize research ...
3/24/2021 Nanoparticle flu shot blocks seasonal and pandemic strains ... National Institute of Allergy and Infectious Diseases at the National Institutes of Health.Influenza virus causes an estimated 290,000‚Ai650,000 deaths per year. Available flu vaccines, which need to be taken seasonally, often fail to protect against many circulating flu strains that cause illness, and the threat of another influenza pandemic looms.‚AuMost flu shots available today are quadrivalent, meaning they are made from four different flu strains. Each year ...
3/24/2021 Red Flags on AstraZeneca's COVID Vaccine Trial Data ... National Institute of Allergy and Infectious Diseases (NIAID) said the Data and Safety Monitoring Board, a panel of medical experts under the National Institutes of Health that has been overseeing AstraZeneca's U.S. trial, had notified government agencies and AstraZeneca late Monday that it was "concerned" by information the company had released.The monitoring board said the company may have relied on "outdated information" that "may have provided an incomplete view ...
3/24/2021 Dr. Fauci: Not turning corner yet on coronavirus | WFRV Local 5 - Green Bay, Appleton Mar 24, 2021 / 10:49 AM CDT / Updated: Mar 24, 2021 / 10:49 AM CDTDr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, listens during a Senate Senate Health, Education, Labor, and Pensions Committee Hearing on the federal government response to COVID-19 Capitol Hill on Wednesday, Sept. 23, 2020, in Washington. (Graeme Jennings/Pool via AP)WASHINGTON ‚Ai Dr. Anthony ...
3/24/2021 New Nanoparticle Flu Vaccine Blocks Many Seasonal and Pandemic Strains ... National Institute of Allergy and Infectious Diseases at the National Institutes of Health.Influenza virus causes an estimated 290,000-650,000 deaths per year. Available flu vaccines, which need to be taken seasonally, often fail to protect against many circulating flu strains that cause illness, and the threat of another influenza pandemic looms.Neil King of the Department of Biochemistry at the University of Washington School of Medicine and a researcher at ...
3/23/2021 AstraZeneca Vaccine Trial Data Questioned by US Health Officials - TheStreet TheStreet ... in the data release of its recent coronavirus vaccine trial.The Data Safety Monitoring Board (DSMB), a division of the National Institutes of Health that oversees new drug trials -- but is not involved in their ... website .Dr. Anthony Fauci, who leads the NIH's National Institute of Allergy and Infectious Diseases, told ABC's Good Morning America program Tuesday that the AstraZeneca vaccine is "very likely a very ...
3/23/2021 Covid: U.S. health agency casts doubt over AstraZeneca vaccine data CNBC ... have included outdated information from that trial, which may have provided an incomplete view of the efficacy data," the U.S. National Institute of Allergy and Infectious Diseases said in a statement ."We urge the company ... advisor Dr. Anthony Fauci, the NIAID is part of the National Institutes of Health.Fauci told ABC News' "Good Morning America" on Tuesday that the Oxford-AstraZeneca shot is "likely a very good vaccine." However ...
3/23/2021 AstraZeneca says data is ‘consistent’ with previous analysis after use of outdated results for COVID-19 vaccine is questioned NY Daily News New York Daily News Mar 23, 2021 at 8:21 AM AstraZeneca, the British-Swedish pharmaceutical company hoping to bring its COVID-19 vaccine to the U.S., said Tuesday that the results of a trial here went exactly as planned despite doubts cast by federal health officials on the accuracy of efficacy data. The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, offered a rare ...
3/23/2021 AstraZeneca COVID-19 vaccine hits new snag as government experts warn of ‚Äòoutdated information‚Äô in trial results Washington Examiner ... National Institutes of Health‚Aos committee of clinical trial analysts ‚Auexpressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data,‚Au according to a message from the government-run National Institute of Allergy and Infectious Diseases.ASTRAZENECA COVID-19 VACCINE 100% EFFECTIVE AT PREVENTING HOSPITALIZATIONS, COMPANY SAYSThe announcement early Tuesday morning came just hours after the ...
3/22/2021 Addiction and COVID-19: A Conversation with Dr. Anthony Fauci and Dr. Nora Volkow Addiction Policy Forum invites you to a webinar with Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID) and Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA), both part of the National Institutes of Health, about the intersection of the addiction and the COVID-19 pandemic. Topics covered will include the impact on people with substance use disorders, the latest on ...
3/17/2021 Contrasting Moderna (NASDAQ:MRNA) & ADMA Biologics (NASDAQ:ADMA) ... National Institute of Allergy and Infectious Diseases, the National Institutes of Health, the Coalition for Epidemic Preparedness Innovations, and Bill & Melinda Gates Foundation. Moderna, Inc. also has collaborations with Lonza Ltd. for the manufacture of COVID-19 vaccine; and Catalent Inc., Laboratorios Farmac√E¬©uticos Rovi, S.A., and Recipharm for fill-finish manufacturing of its COVID-19 vaccine candidate. The company was formerly known as Moderna Therapeutics, Inc. and changed ...
3/17/2021 Examining Our COVID-19 Response: An Update from Federal Officials US Senate Hearings Full Committee Hearing Examining Our COVID-19 Response: An Update from Federal Officials Date: Thursday, March 18, 2021 Add to my Calendar Time: 10:00 AM Location: 216 Hart Senate Office Building Check back for live video of this hearing. Witnesses Director, National Institute of Allergy and Infectious Diseases National Institutes of Health ...
3/16/2021 Moderna Announces First Participants Dosed in Phase 2/3 Study of COVID-19 Vaccine Candidate in Pediatric Population | Financial Buzz ... National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services.‚AuWe are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the U.S. and Canada and we thank NIAID ...
3/16/2021 Kansas native and 'father of COVID vaccines' to give presentation through K-State | | junctioncityunion.com ... National Institute of Allergy and Infectious Diseases Vaccine Research Center at the National Institutes of Health, is to be the featured guest in a webinar from K-State Research and Extension and Lafene Health Center on March 18.The presentation, ‚Au Rapid COVID-19 Vaccine Development: Why and How,‚Au will be live on YouTube starting at 7 p.m. It also will be on the K-State Research and Extension ...
3/16/2021 The Daily 202: Biden blueprint for getting Republicans vaccinated: Faith, friends, and Francis The Washington Post ... National Institutes of Health Director Francis Collins, a devout Christian known to get up before 4 a.m. to make time for prayer and Bible study, and the author of ‚AuLanguage of God: A Scientist Presents Evidence for Belief.‚Au He's an apt ambassador to bring Biden‚Aos health message to communities of faith. Collins and National Institute of Allergy and Infectious Diseases Director Anthony Fauci ‚Ai joined by 25 interfaith ...
3/16/2021 Moderna starts testing of COVID-19 vaccine candidate in children - MarketWatch MarketWatch 8.60% said Tuesday that it has dosed the first pediatric participants of its KidCOVE Phase 2/3 study of its COVID-19 vaccine candidate, which is being tested for children aged 6 months to less than 12 years. Moderna's stock rose 1.8% in premarket trading. The study is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) and ...
3/16/2021 Moderna starts testing of COVID-19 vaccine candidate in children - MarketWatch MarketWatch Moderna Inc. MRNA, +4.87% said Tuesday that it has dosed the first pediatric participants of its KidCOVE Phase 2/3 study of its COVID-19 vaccine candidate, which is being tested for children aged 6 months to less than 12 years. Moderna's stock rose 1.8% in premarket trading. The study is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of ...
3/16/2021 Moderna Announces First Pediatric Phase 2/3 to Study Participants Dosed | Hamodia.com ... National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services.‚AuWe are pleased to begin this Phase 2/3 study of mRNA-1273 in healthy children in the U.S. and Canada and we thank NIAID ...
3/12/2021 New Ebola outbreak likely sparked by a person infected 5 years ago The Ebola virus may cause latent infections in survivors that could spark new outbreaks. National Institute of Allergy and Infectious Diseases/National Institutes of Health/Flickr ( CC BY-NC 2.0 ) New Ebola outbreak likely sparked by a person infected 5 years ago By Kai Kupferschmidt Mar. 12, 2021 , 1:15 PMAn Ebola outbreak in Guinea that has so far sickened at least 18 people and killed nine has stirred difficult ...
3/12/2021 New Ebola Outbreak Likely Sparked By A Person Infected 5 Years Ago - NewsOpener The Ebola virus may cause latent infections in survivors that could spark new outbreaks.Related Articles Astronomer Avi Loeb Says Aliens Have Visited, and He‚Aos Not Kidding February 1, 2021 Dress like an Alaskan to weather the winter cold January 20, 2021National Institute of Allergy and Infectious Diseases/National Institutes of Health/Flickr ( CC BY-NC 2.0 )By Kai Kupferschmidt Mar. 12, 2021 , 1:15 PMAn Ebola outbreak ...
3/11/2021 NIH awards grants to support bacteriophage therapy research National Institutes of Health NIH awards grants to support bacteriophage therapy research ‚AuPhage‚Au therapies offer potential strategy to combat antibacterial resistance. A computer-generated rendition of a bacteriophage NIAIDThe National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded $2.5 million in grants to 12 institutes around the world to support research on bacteriophage therapy. These awards represent NIAID‚Aos first series of grants focused ...
3/11/2021 Staff Scientist, Cellular Immunology Section National Institutes of Health Staff Scientist, Cellular Immunology Section Job Announcement DescriptionThe National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC) is recruiting for a staff scientist in the Cellular Immunology Section (CIS) at the National Institutes of Health (NIH).The VRC is seeking a candidate to join the highly active CIS, which is part of the Immunology Laboratory (IML). The CIS seeks to provide a mechanistic basis for developing ...
3/11/2021 NIH awards grants to support bacteriophage therapy research NIH awards grants to support bacteriophage therapy research "Phage" therapies offer potential strategy to combat antibacterial resistance NIH/National Institute of Allergy and Infectious DiseasesIMAGE: A computer-generated rendition of a bacteriophage. view more Credit: NIAIDThe National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded $2.5 million in grants to 12 institutes around the world to support research on bacteriophage ...
3/11/2021 NIAID awards $2.5 million in grants to support research on bacteriophage therapy The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded $2.5 million in grants to 12 institutes around the world to support research on bacteriophage therapy. These awards represent NIAID's first series of grants focused exclusively on research on this therapy, an emerging field that could yield new ways to fight antimicrobial-resistant bacteria. A 2019 report from CDC found that antibiotic ...
3/10/2021 In The '24th Mile' Of A Marathon, Fauci And Collins Reflect On Their Pandemic Year ... National Institute of Allergy and Infectious Diseases and a member of former President Trump's White House coronavirus task force, and his boss, Dr. Francis Collins, director of the National Institutes of Health.As they reflect on the past year, they both express surprise, and disappointment, at the unanticipated challenges they faced in getting public health messages out effectively."I think one of the diagnoses that comes out of this last ...